Dergiler / Yeni Tıp Dergisi / 2013 / Cilt: 30 - Sayı: 2
Kanser hastalarında ortalama platelet volümü platelet sayısı, risk faktörleri ile tromboembolik olaylar arasındaki ilişki
- Dergi
- Yeni Tıp Dergisi
- Sayfa
- 89–92
- DOI
- —
Özet
Objective: For platelet volume, mean platelet volume is an indicator. We aimed to investigate the relationship among mean platelet volume, platelet count with thromboembolic event and detected risk factors for thromboemboli in patients who were newly diagnosed during one year follow-up. Material and Method: Consecutive 168 patients suffering from cancer have been followed-up for one year. Mean platelet volume an d platelet count, age, sex, cancer type, stage, comorbidity, smoking, chemotherapy intake and thromboembolic events were analysed. Results: While in the post treatment mean platelet volume a significant decrease was seen, post treatment platelet were counted as similar values according to first values at the time of diagnosis in patients of thromboembolic events (+). Chemotherapy intake and smoking were the risk factors for thromboemboli; smoking was the only independent one among these factors. Conclusion: During chemotherapy period, prophylaxis for thromboembolic event should be offered to the patients who were newly diagnosed with cancer for one year especially to whom with smoking.
Abstract
Objective: For platelet volume, mean platelet volume is an indicator. We aimed to investigate the relationship among mean platelet volume, platelet count with thromboembolic event and detected risk factors for thromboemboli in patients who were newly diagnosed during one year follow-up. Material and Method: Consecutive 168 patients suffering from cancer have been followed-up for one year. Mean platelet volume an d platelet count, age, sex, cancer type, stage, comorbidity, smoking, chemotherapy intake and thromboembolic events were analysed. Results: While in the post treatment mean platelet volume a significant decrease was seen, post treatment platelet were counted as similar values according to first values at the time of diagnosis in patients of thromboembolic events (+). Chemotherapy intake and smoking were the risk factors for thromboemboli; smoking was the only independent one among these factors. Conclusion: During chemotherapy period, prophylaxis for thromboembolic event should be offered to the patients who were newly diagnosed with cancer for one year especially to whom with smoking.